Key result
Higher Cardiometabolic Index linked to ~101% greater CVD risk in diabetic patients.
Why the study?
Understanding the predictive role of the Cardiometabolic Index in assessing CVD risk is essential for enhancing preventive strategies in diabetic patients.
Is a higher Cardiometabolic Index associated with an increased risk of cardiovascular disease in diabetic patients?
Population
Diabetic participants from NHANES (n = 2044) and CHARLS (n = 3964)
Comparison
Higher CMI vs lower CMI
Design
Cross-sectional analysis of two national cohorts
Authors
Loading...
CMI was associated with CVD risk in diabetes; hypothesis-generating and requires prospective validation before clinical adoption.
Cross-Sectional (n=6,008)
Yes
Is a higher Cardiometabolic Index associated with an increased risk of cardiovascular disease in diabetic patients?
Effect estimate: OR 2.01 (NHANES); OR 1.45 (CHARLS)
p-value: p=0.0074 (NHANES); 0.009 (CHARLS)
The Cardiometabolic Index is a robust and independent predictor of cardiovascular disease risk among diabetic individuals across different populations.
Liu et al. (2025) conducted a cross-sectional in Diabetes (n=6,008). Cardiometabolic Index (CMI) was evaluated on Cardiovascular disease (CVD) risk (OR 2.01 (NHANES); OR 1.45 (CHARLS), p=0.0074 (NHANES); 0.009 (CHARLS)). A higher Cardiometabolic Index was significantly associated with increased cardiovascular disease risk in diabetic patients from the NHANES (OR 2.01, p=0.0074) and CHARLS (OR 1.45, p=0.009) cohorts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: